New injection aims to smooth wrinkles without surgery

NCT ID NCT07383766

Completed Symptom relief Sponsor: Erevna Innovations Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study tests a skin booster injection called Revanesse Renew+ to improve facial wrinkles. The gel contains hyaluronic acid, which hydrates the skin. Researchers will compare two treatment schedules (every two weeks vs. monthly) in 14 adults aged 30 and older. The goal is to see which schedule works better and is safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hyaluronic acid gel (Revanesse® Renew™+)
What this could lead to: If successful, this could provide an evidence-based treatment schedule for reducing facial wrinkles using a skin booster injection.
What could go wrong: This is a very small early-phase study with only 14 participants, so results may not apply broadly. Side effects like redness or swelling are possible with injections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AESTHETIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AESTHETIC

Contacts and locations

Locations

Erevna Innovations Inc.

Montreal, Quebec, H3Z 1C3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.